Indication
Lennox-Gastaut epilepsy
Lennox-Gastaut epilepsy, commonly referred to as Lennox-Gastaut syndrome (LGS), is a severe, lifelong developmental and epileptic encephalopathy that typically manifests in early childhood between the ages of two and eight years. Read more about Lennox-Gastaut epilepsy
201 drugs 101 manufacturers
Drugs that treat it
Common Lennox-Gastaut epilepsy therapies.
KLONOPIN (clonazepam)
LAMICTAL STARTER (ORANGE) KIT (lamotrigine)
LAMICTAL STARTER (BLUE) KIT (lamotrigine)
LAMICTAL STARTER (GREEN) KIT (lamotrigine)
LAMICTAL ODT STARTER (GREEN) (lamotrigine)
LAMICTAL ODT STARTER (BLUE) (lamotrigine)
LAMICTAL ODT STARTER (ORANGE) (lamotrigine)
SUBVENITE STARTER (BLUE) KIT (lamotrigine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLennox-Gastaut epilepsy, commonly referred to as Lennox-Gastaut syndrome (LGS), is a severe, lifelong developmental and epileptic encephalopathy that typically manifests in early childhood between the ages of two and eight years.
Primarily affecting the central nervous system, it is clinically characterized by a triad of multiple drug-resistant seizure types—most notably tonic, atonic, and atypical absence seizures—alongside moderate to severe cognitive impairment and behavioral disturbances.
The defining pathophysiologic neurodiagnostic features include generalized interictal slow spike-and-wave discharges of less than 3 Hz during wakefulness and generalized paroxysmal fast activity during sleep.
Frequent tonic and atonic episodes frequently trigger precipitous drop attacks, presenting a high risk for recurrent injury and status epilepticus.
- nih.gov
Lennox-Gastaut epilepsy, commonly referred to as Lennox-Gastaut syndrome (LGS), is a severe, lifelong developmental and epileptic encephalopathy that typically manifests in early childhood between the ages of two and eight years
- nih.gov
Lennox-Gastaut epilepsy, commonly referred to as Lennox-Gastaut syndrome (LGS), is a severe, lifelong developmental and epileptic encephalopathy that typically manifests in early childhood between the ages of two and eight years Primarily affecting the central nervous system, it is clinically characterized by a triad of multiple drug-resistant seizure types—most notably tonic, atonic, and atypical absence seizures—alongside moderate to severe cognitive impairment and behavioral disturbances
- ucb.com
Lennox-Gastaut epilepsy, commonly referred to as Lennox-Gastaut syndrome (LGS), is a severe, lifelong developmental and epileptic encephalopathy that typically manifests in early childhood between the ages of two and eight years
- medlineplus.gov
Primarily affecting the central nervous system, it is clinically characterized by a triad of multiple drug-resistant seizure types—most notably tonic, atonic, and atypical absence seizures—alongside moderate to severe cognitive impairment and behavioral disturbances The defining pathophysiologic neurodiagnostic features include generalized interictal slow spike-and-wave discharges of less than 3 Hz during wakefulness and generalized paroxysmal fast activity during sleep Frequent tonic and atonic...
- nih.gov
Primarily affecting the central nervous system, it is clinically characterized by a triad of multiple drug-resistant seizure types—most notably tonic, atonic, and atypical absence seizures—alongside moderate to severe cognitive impairment and behavioral disturbances
- nih.gov
The defining pathophysiologic neurodiagnostic features include generalized interictal slow spike-and-wave discharges of less than 3 Hz during wakefulness and generalized paroxysmal fast activity during sleep Frequent tonic and atonic episodes frequently trigger precipitous drop attacks, presenting a high risk for recurrent injury and status epilepticus
- epilepsydiagnosis.org
The defining pathophysiologic neurodiagnostic features include generalized interictal slow spike-and-wave discharges of less than 3 Hz during wakefulness and generalized paroxysmal fast activity during sleep
- aan.com
Frequent tonic and atonic episodes frequently trigger precipitous drop attacks, presenting a high risk for recurrent injury and status epilepticus
Personalize your experience
Follow Lennox-Gastaut epilepsy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.